Status:
NOT_YET_RECRUITING
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
Lead Sponsor:
Erasmus Medical Center
Conditions:
Hilar Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)
Eligibility:
All Genders
18+ years
Brief Summary
In the POELH-II trial (Clinicaltrials.gov ID NCT05678218) patients with presumed resectable perihilar (pCCA), intrahepatic (iCCA) or mid-common bile duct (CBD) cholangiocarcinoma had the outcomes of t...
Eligibility Criteria
Inclusion
- Presumed resectable pCCA OR
- Presumed resectable iCCA OR
- Presumed resectable mid-common bile duct CCA OR
- Presumed unresectable pCCA worked-up for Liver Transplantation AND
- Written informed consent must be given according to International Council on Harmonisation/Good Clinical Practice guidelines, and national/local regulations AND
- Age \> 18 years.
Exclusion
- Patients with a history of treated CCA
- Patients with CCA for which a pancreatoduodenectomy is indicated, based on cross-sectional imaging
- Patients with a history of treated liver malignancy
- Patients with a contra-indication for EUS-tissue acquisition (f.e. uncorrectable coagulopathy or platelet disorder), in line with current clinical practice
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2028
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT07161869
Start Date
October 1 2025
End Date
November 1 2028
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC University Medical Center
Rotterdam, South Holland, Netherlands, 3015 CN